Sensing technology developed by Dr. Mohseni's research team pending FDA approval

ClotChip, a portable blood-testing device initially developed at Case Western Reserve, is a step closer to U.S. Food and Drug Administration review after drawing more than $9 million in investments.

A university research team led by Pedram Mohseni, PhD, professor of electrical engineering and computer science, developed the device's sensing technology.

The idea for the instrument came in 2010 when then doctoral student Mehran Bakhshiani, PhD (GRS '15, electrical engineering and applied physics) was working with Mohseni and senior research associate Michael Suster, PhD (CWR '02; GRS '04, '11, electrical engineering and applied physics), to develop a technology to measure the response of certain liquids to an external electric field.

You can read the full article from Think Magazine here.